Global Subdermal Contraceptive Implants Market By Type (Jadelle, Sino-implant, Nexplanon), By End user (Hospitals, Clinics, Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2029
Subdermal Contraceptive Implants Market Outlook
The global Subdermal Contraceptive Implants market was valued at USD 966.4 Million in 2021 and is projected to reach USD 1,760.4 Million by 2029, expanding at a CAGR of 8.4% during the forecast period. The subdermal contraceptive implant is a small, flexible rod that is inserted under the skin of the inner upper arm. It slowly releases a progestogen hormone to prevent pregnancy for a long period of time which ranges from three to five years.
One of the common hormones used in contraceptive implants is progestogen, which is similar to the natural hormone progesterone that is synthesized by the female body. The implants are inserted subdermally, under local anesthesia with the use of a trocar, in the inner aspect of the non-dominant arm.
The implant works by preventing the release of the egg from the ovary (blocking the ovulation cycle) and restricts the entry of sperm to the uterus (womb) by thickening the cervical mucus.
Subdermal contraceptive implant is an effective method of birth control with a scientifically proven efficacy of more than 99% indicating that fewer than 1 in every 100 women using the implant method gets impregnated. Hence, it is one of the safest contraceptive option owing to the low failure rate. However, the effectiveness of subdermal contraceptive implant reduces due to the effect of other medications consumed simultaneously. These include some of the medicines used to treat HIV, epilepsy, tuberculosis (TB), and other high concentrate medicine.
A subdermal contraceptive implant has no serious side effects. Major side effects associated with the use of contraceptive implants are changes in frequency, duration, and amount of menstrual bleeding patterns. Some rare and minor side effects reported are infection at the site of the implant and ovarian cyst. All symptoms of side effects are temporary and fade out once the body gets metabolically adjusted to the implanted contraceptive device.
The continuation rate of subdermal contraceptive implant is higher, indicating continued use of the product after implanting it. According to research conducted by Cochrane Review, more than 80% of women continue the use their implant over two years of implantation. Various clinical trials and observational studies in a number of countries reported the continuation rates for implants to range between 78% to 96% at one year, and between 50% to 86% at three years.
Scope of Subdermal Contraceptive Implants Market Report
The report on the Subdermal Contraceptive Implants market includes an assessment of the market, size, share, trends, segments, and country markets. Overview and dynamics have been included in the report.
Attributes |
Details |
Report Title |
Subdermal Contraceptive Implants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2019 & 2020 |
Forecast Period |
2022–2029 |
Segmentation |
By Type (Jadelle, Sino-implant, Nexplanon), End user (Hospitals, Clinics, Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Merck & Co., Inc (Organon & Co.), Bayer AG, Shanghai Dahua Pharmaceutical Co., Ltd. |
Subdermal Contraceptive Implants Market Dynamics
Rise in sexual and reproductive health awareness
Various countries are gearing up their awareness initiatives to address sexual and reproductive health issues with the vision to reduce pregnancy-related health disorders. Increase in awareness and proper guidance on contraceptives make adolescents more well informed of sexual safety.
The growing sex education in recent times has resulted not only in improvements in health-related outcomes such as reduced unintended pregnancies, high-risk pregnancies, maternal mortality, and infant mortality but also in improvements in schooling and economic outcomes, especially for girls and women. Hence, rise in sexual health awareness has widely promoted the use of subdermal contraceptive implants.
Long Term Contraceptive Solution
Subdermal Contraceptive Implants are used as effective long term contraceptive solution as it is meant for 3 to 5 years of use after its implantation in body. Women who use long-acting methods of birth control are less likely to wind up pregnant than women who use shorter-term methods, which require daily or monthly remembering. Long term contraceptives are 99% effective birth control solution (probability of getting pregnant even after the use of subdermal contraceptive implants is less than 1%) and thus the use of subdermal contraceptive implants is projected to grow over the forecast period.
Low Adaptability of Subdermal Contraceptive Implants Device
The adaptability of subdermal contraceptive implant is low as compared to other contraceptive options. In spite of healthcare infrastructure development, and its awareness in family planning programs around the globe, contraceptive implants are not used as primary contraceptive method. This can be attributed to low availability of the device and sophisticated implantation surgeries which is mandatorily done by medical professionals. Hence, the use of subdermal contraceptive implants device is low in the regions where availability of other contraceptives such as oral pills are prevalent.
Comparatively Fewer Side Effects with High Efficacy
Subdermal Contraceptive Implants have comparatively lesser side effects than other contraceptives option. Potential side effects include headaches, abdominal pain, weight gain, nausea, mood swings, dizziness, acne, and breast tenderness. However, side effects reported after the use of subdermal contraceptive implants are minimal, remain prevalent until body gets used to the implant and usually fade away after a few months.
Rarely, the side effects are serious. Hence, as subdermal contraceptive implants is regarded one of the safest contraceptive method compared to other alternatives, and its prevalence is expected to rise over the forecast period.
Subdermal Contraceptive Implants Market Segmental Outlook
Based on type, the subdermal contraceptive implants market is segmented into jadelle, sino-implant, and nexplanon. Jadelle is expected to hold a significant share in subdermal contraceptive implants market during the forecast period as it effective and reversible contraceptive that inhibits pregnancy up to 5 years. It is one of the most effective implant contraception available in the market. Sino-implant segment is expected to expand at rapid growth rate during the forecast period.
Sino-implant is prequalified for maximum 3 years of use with shell life of 4 years. Its accuracy rate is 99% which indicates that fewer than 1 pregnancy per 100 users is reported. Sino-implant has been registered by more than 20 drug regulatory authorities worldwide. Nexplanon segment is projected to grow at a rapid pace during the forecast period as it is a hormone-releasing birth control implant to prevent pregnancy for up to 3 years.
It steadily releases a small dose of the hormone progestogen into users bloodstream which prevents the egg from being released from the ovary, and thickens cervical mucous to prevent sperm from reaching an egg.
Based on end-users, the subdermal contraceptive implants market is classified as hospitals, clinics, and others. The hospitals segment is expected to hold a significant share of the subdermal contraceptive implants market during the forecast period, as the insertion of contraceptives under the arm skin cannot be legally performed by patients and require professional medical practitioners to safely install the device.
The clinics segment is expected to expand at rapid growth rate during the forecast period. The patient is required to visit clinics to implant subdermal contraceptives, especially in undeveloped and developing regions due to less number of hospitals. The others segment is projected to grow at a steady pace during the forecast period.
The segment include ambulatory surgical centers, research centers, and medical institutions. The demand for subdermal contraceptive implants from various other end-users is increasing owing to growing R&D activities and technological advancements in the contraceptive medical device industry.
Subdermal Contraceptive Implants Market Regional Outlook
Based on the regions, the Global Subdermal Contraceptive Implants Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The Middle East & Africa region is projected to account significant market share and is anticipated to dominate the global market in coming years owing to increasing preference for implantable contraceptives over traditional methods. Moreover, their cost-effectiveness, long-term contraceptive solution, and low risk of pelvic inflammatory disease are expected to fuel the market in the region. Increasing adoption of subdermal contraceptive implants due to the surging population and rising cases of unwanted pregnancies is expected to propel the market in Asia Pacific during the forecast period.
North America holds a major share in the global subdermal contraceptive implant market, owing to increasing technological development in contraceptive science in the region. The market in the region is projected to grow, as the female population is adopting modern methods of contraception such as subdermal contraceptive implant, as they are safe and offer high efficacy.
The market in Europe is anticipated to grow at a substantial pace in the coming years, despite the low fertility rate in Europe owing to high awareness about contemporary contraception, presence of well-established healthcare infrastructure, and priority to safe and effective contraceptive methods.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Subdermal Contraceptive Implants Market
- Historical, Current, and Projected Market Size in terms of Value.
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints, and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Subdermal Contraceptive Implants Market Performance
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Subdermal Contraceptive Implants Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Subdermal Contraceptive Implants Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Subdermal Contraceptive Implants Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Subdermal Contraceptive Implants Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Subdermal Contraceptive Implants Market Size & Forecast, 2018-2028
4.5.1 Subdermal Contraceptive Implants Market Size and Y-o-Y Growth
4.5.2 Subdermal Contraceptive Implants Market Absolute $ Opportunity
4.6 Pricing Analysis & Forecast, By Type, 2018-2028
4.7 Global Subdermal Contraceptive Implants Market: Impact Of Key Regulations
Chapter 5 Global Subdermal Contraceptive Implants Market Analysis and Forecast By Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Type
5.1.2 Basis Point Share (BPS) Analysis By Type
5.1.3 Absolute $ Opportunity Assessment By Type
5.2 Subdermal Contraceptive Implants Market Size & Volume Forecast By Type
5.2.1 Jadelle
5.2.2 Sino-implant
5.2.3 Nexplanon
5.3 Market Attractiveness Analysis By Type
Chapter 6 Global Subdermal Contraceptive Implants Market Analysis and Forecast By End user
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By End user
6.1.2 Basis Point Share (BPS) Analysis By End user
6.1.3 Absolute $ Opportunity Assessment By End user
6.2 Subdermal Contraceptive Implants Market Size & Volume Forecast By End user
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis By End user
Chapter 7 Global Subdermal Contraceptive Implants Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Subdermal Contraceptive Implants Market Size & Volume Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Subdermal Contraceptive Implants Analysis and Forecast
9.1 Introduction
9.2 North America Subdermal Contraceptive Implants Market Size & Volume Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Subdermal Contraceptive Implants Market Size & Volume Forecast By Type
9.6.1 Jadelle
9.6.2 Sino-implant
9.6.3 Nexplanon
9.7 Basis Point Share (BPS) Analysis By Type
9.8 Absolute $ Opportunity Assessment By Type
9.9 Market Attractiveness Analysis By Type
9.10 North America Subdermal Contraceptive Implants Market Size & Volume Forecast By End user
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis By End user
9.12 Absolute $ Opportunity Assessment By End user
9.13 Market Attractiveness Analysis By End user
Chapter 10 Europe Subdermal Contraceptive Implants Analysis and Forecast
10.1 Introduction
10.2 Europe Subdermal Contraceptive Implants Market Size & Volume Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Subdermal Contraceptive Implants Market Size & Volume Forecast By Type
10.6.1 Jadelle
10.6.2 Sino-implant
10.6.3 Nexplanon
10.7 Basis Point Share (BPS) Analysis By Type
10.8 Absolute $ Opportunity Assessment By Type
10.9 Market Attractiveness Analysis By Type
10.10 Europe Subdermal Contraceptive Implants Market Size & Volume Forecast By End user
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis By End user
10.12 Absolute $ Opportunity Assessment By End user
10.13 Market Attractiveness Analysis By End user
Chapter 11 Asia Pacific Subdermal Contraceptive Implants Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Subdermal Contraceptive Implants Market Size & Volume Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Subdermal Contraceptive Implants Market Size & Volume Forecast By Type
11.6.1 Jadelle
11.6.2 Sino-implant
11.6.3 Nexplanon
11.7 Basis Point Share (BPS) Analysis By Type
11.8 Absolute $ Opportunity Assessment By Type
11.9 Market Attractiveness Analysis By Type
11.10 Asia Pacific Subdermal Contraceptive Implants Market Size & Volume Forecast By End user
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis By End user
11.12 Absolute $ Opportunity Assessment By End user
11.13 Market Attractiveness Analysis By End user
Chapter 12 Latin America Subdermal Contraceptive Implants Analysis and Forecast
12.1 Introduction
12.2 Latin America Subdermal Contraceptive Implants Market Size & Volume Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Subdermal Contraceptive Implants Market Size & Volume Forecast By Type
12.6.1 Jadelle
12.6.2 Sino-implant
12.6.3 Nexplanon
12.7 Basis Point Share (BPS) Analysis By Type
12.8 Absolute $ Opportunity Assessment By Type
12.9 Market Attractiveness Analysis By Type
12.10 Latin America Subdermal Contraceptive Implants Market Size & Volume Forecast By End user
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis By End user
12.12 Absolute $ Opportunity Assessment By End user
12.13 Market Attractiveness Analysis By End user
Chapter 13 Middle East & Africa (MEA) Subdermal Contraceptive Implants Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Subdermal Contraceptive Implants Market Size & Volume Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Subdermal Contraceptive Implants Market Size & Volume Forecast By Type
13.6.1 Jadelle
13.6.2 Sino-implant
13.6.3 Nexplanon
13.7 Basis Point Share (BPS) Analysis By Type
13.8 Absolute $ Opportunity Assessment By Type
13.9 Market Attractiveness Analysis By Type
13.10 Middle East & Africa (MEA) Subdermal Contraceptive Implants Market Size & Volume Forecast By End user
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis By End user
13.12 Absolute $ Opportunity Assessment By End user
13.13 Market Attractiveness Analysis By End user
Chapter 14 Competition Landscape
14.1 Subdermal Contraceptive Implants Market: Competitive Dashboard
14.2 Global Subdermal Contraceptive Implants Market: Market Share Analysis, 2020
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co., Inc (Organon & Co.)
14.3.2 Bayer AG
14.3.3 Shanghai Dahua Pharmaceutical Co., Ltd.